Codexis, Inc. (CDXS)
2.52
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 10:10
Codexis Total Assets (Quarterly) : 147.80M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 136.87B |
| Incyte Corp. | 6.971B |
| Niagen Bioscience, Inc. | 106.41M |
| MacroGenics, Inc. | 264.57M |
| Viridian Therapeutics, Inc. | 899.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 97.27M |
| Shareholders Equity (Quarterly) | 50.53M |
| Debt to Equity Ratio | 1.449 |
| Current Ratio | 3.824 |
| Net Debt Paydown Yield | -4.25% |